Monensin
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB11430 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | osteogenesis imperfecta | KG + DL |
| 2 | congenital stationary night blindness autosomal dominant | KG + DL |
| 3 | deafness, autosomal recessive | KG + DL |
| 4 | immunodeficiency-centromeric instability-facial anomalies syndrome | KG + DL |
| 5 | myelodysplasia, immunodeficiency, facial dysmorphism, short stature, and psychomotor delay | KG + DL |
| 6 | bone dysplasia, lethal Holmgren type | KG + DL |
| 7 | agammaglobulinemia | KG + DL |
| 8 | action myoclonus-renal failure syndrome | KG + DL |
| 9 | arthrogryposis, distal, | KG + DL |
| 10 | craniosynostosis-intracranial calcifications syndrome | KG + DL |
| 11 | ectodermal dysplasia with facial dysmorphism and acral, ocular, and brain anomalies | KG + DL |
| 12 | dyskeratosis congenita, autosomal recessive | KG + DL |
| 13 | primary microcephaly | KG + DL |
| 14 | Summitt syndrome | KG + DL |
| 15 | familial visceral amyloidosis | KG + DL |
| 16 | immunodeficiency, common variable | KG + DL |
| 17 | vitamin B12-responsive methylmalonic acidemia | KG + DL |
| 18 | congenital nystagmus | KG + DL |
| 19 | hidrotic ectodermal dysplasia, Christianson-Fourie type | KG + DL |
| 20 | congenital hypotrichosis with juvenile macular dystrophy | KG + DL |
| 21 | mucocutaneous ulceration, chronic | KG + DL |
| 22 | primary ciliary dyskinesia | KG + DL |
| 23 | cataract | KG + DL |
| 24 | familial hyperthyroidism due to mutations in TSH receptor | KG + DL |
| 25 | phocomelia-ectrodactyly-deafness-sinus arrhythmia syndrome | KG + DL |
| 26 | Böök syndrome | KG + DL |
| 27 | Charcot-Marie-Tooth disease with ptosis and parkinsonism | KG + DL |
| 28 | megalocornea-intellectual disability syndrome | KG + DL |
| 29 | peeling skin syndrome | KG + DL |
| 30 | Ehlers-Danlos syndrome due to tenascin-X deficiency | KG + DL |
| 31 | spermatogenic failure | KG + DL |
| 32 | platelet-type bleeding disorder | KG + DL |
| 33 | mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency | KG + DL |
| 34 | trichorhinophalangeal syndrome | KG + DL |
| 35 | agonadism, 46,XY, with intellectual disability, short stature, retarded bone age, and multiple extragenital malformations | KG + DL |
| 36 | hypochondroplasia | KG + DL |
| 37 | ataxia telangiectasia | KG + DL |
| 38 | keratosis pilaris | KG + DL |
| 39 | trichothiodystrophy photosensitive | KG + DL |
| 40 | acromesomelic dysplasia | KG + DL |
| 41 | azotemia, familial | KG + DL |
| 42 | myoclonic epilepsy, juvenile, susceptibility to | KG + DL |
| 43 | X-linked progressive cerebellar ataxia | KG + DL |
| 44 | ulnar/fibula ray defect-brachydactyly syndrome | KG + DL |
| 45 | Smith-McCort dysplasia | KG + DL |
| 46 | amyotrophic lateral sclerosis | KG + DL |
| 47 | autosomal dominant macrothrombocytopenia | KG + DL |
| 48 | Nager acrofacial dysostosis | KG + DL |
| 49 | hypophosphatemia, renal, with intracerebral calcifications | KG + DL |
| 50 | benign familial neonatal-infantile seizures | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.